Supply Chain Intelligence

Cartesian Therapeutics, Inc. Supply Chain

RNAC supply chain intelligence for Cartesian Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

RNAC ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
3Customers
3Debt Items
20Related Chains

Cartesian Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
SHENYANG-SUNSHINE-PHARMACEUTICAL-CO-LTD SHENYANG-SUNSHINE-PHARMACEUTICAL-CO-LTD 92% The Company has paid to 3SBio an aggregate of $ 7.0 million in upfront and milestone-based payments under the 3SBio License as of March 31, 2026.
CRBU Caribou Biosciences, Inc. 72% Reciprocal relationship from CRBU graph: untries where our product candidates may be sold at lower prices than in the United States. Third-party payors, whether domestic or foreign, governmental or c…
FATE Fate Therapeutics, Inc. 72% Reciprocal relationship from FATE graph: rt that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purpos…

Cartesian Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
CRBU Caribou Biosciences, Inc. 72% Reciprocal relationship from CRBU graph: untries where our product candidates may be sold at lower prices than in the United States. Third-party payors, whether domestic or foreign, governmental or c…
FATE Fate Therapeutics, Inc. 72% Reciprocal relationship from FATE graph: Reciprocal relationship from RNAC graph: Reciprocal relationship from FATE graph: Reciprocal relationship from RNAC graph: Reciprocal relationship from FATE g…
KYTX Kyverna Therapeutics, Inc. 72% Reciprocal relationship from KYTX graph: Reciprocal relationship from RNAC graph: Reciprocal relationship from KYTX graph: Reciprocal relationship from RNAC graph: Reciprocal relationship from KYTX g…

Cartesian Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
RNAC-DEBT Debt stack $11.9M 90% Market cache reports total debt of $11.9M.
RNAC-DEBT-12242 Xbrl Convertible 90% xbrl convertible detail from xbrl 2016-12-31.
RNAC-DEBT-12241 Warrants outstanding: 196850 90% xbrl warrant detail from xbrl 2026-03-31.

Cartesian Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cartesian Therapeutics, Inc..

Cartesian Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
RNAC-OWNER-SQUAREPOINT-OPS-LLC Squarepoint Ops LLC 90% 13F overlay lists Squarepoint Ops LLC as top holder; 83 tracked holders.

Cartesian Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
JBIO Jade Biosciences, Inc. 100.00 2
MYGN Myriad Genetics, Inc. 100.00 2
KYTX Kyverna Therapeutics, Inc. 100.00 2 ['customer']
CRBU Caribou Biosciences, Inc. 100.00 2 ['customer', 'supplier']
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
SNYNF Sanofi 100.00 2
FATE Fate Therapeutics, Inc. 100.00 1 ['customer', 'supplier']
JNJ Johnson & Johnson 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
NVSEF Novartis AG 100.00 2
GRFS Grifols, S.A. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
LYEL Lyell Immunopharma, Inc. 100.00 2
AUTL Autolus Therapeutics plc 100.00 2
IPSC Century Therapeutics, Inc. 100.00 2
JAZZ Jazz Pharmaceuticals plc 50.00 2
CGEM Cullinan Therapeutics, Inc. 50.00 2
A Agilent Technologies, Inc. 50.00 2
ACET Adicet Bio, Inc. 50.00 2
BMY Bristol-Myers Squibb Company 50.00 2
View RNAC supply chain intel →

Explore the full interactive supply chain map for Cartesian Therapeutics, Inc..

Open RNAC supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map